Antoine Falcoz is a research engineer in biostatistics who received a master's degree in statistical modeling with honors at the University of Besançon in 2018.

During the first year master’s degree’s internship at the Clinical Methodology Center of Besançon, he worked on a study about thoracic surgery whose purpose was to find prognostic factors of postoperative complications. During his second internship at the Antoine Lacassagne Center of Nice, he worked at the Epidemilogy and Biostatistics Unit where he had the responsibility of the statistics of several clinical trials and epidemiological studies.

In October 2018, he joined the UMQVC at the University Hospital of Besançon.

Derniers articles

sample

AbstractBackground: Trastuzumab is used, alone or in conjunction with standard chemotherapy, to treat HER2-positive...

Posté par : Mr. Antoine FALCOZ, Dr. Dewi VERNEREY
Nom de la revue : Front Cardiovasc Med

sample

AbstractBackground and objective: The CABASTY study showed that more frequent administration of a lower dose of...

Posté par : Dr. Dewi VERNEREY, Mr. Antoine FALCOZ
Nom de la revue : European Urology Oncology

sample

AbstractBackground: We assessed the added value of incorporating carcinoembryonic antigen (CEA) to circulating...

Posté par : Mr. Antoine FALCOZ, Dr. Dewi VERNEREY
Nom de la revue : The Oncologist

sample

AbstractBackground: Stage II colon cancer (CC) exhibits considerable prognostic heterogeneous. Our objective was to...

Posté par : Mr. Antoine FALCOZ, Dr. Dewi VERNEREY
Nom de la revue : Clin Colorectal Cancer.

sample

AbstractBackground: One randomized phase III trial comparing chemotherapy (CT) with immune checkpoint inhibitors...

Posté par : Mr. Antoine FALCOZ, Dr. Dewi VERNEREY
Nom de la revue : Eur J Cancer.

sample

AbstractBackground and aims: Postoperative recurrence is a major concern in Crohn's disease. The Kono-S anastomosis...

Posté par : Mr. Antoine FALCOZ, Dr. Dewi VERNEREY
Nom de la revue : J Crohns Colitis.

sample

AbstractBackground: It is intuitively thought that early relapse is associated with poor survival after recurrence...

Posté par : Mr. Antoine FALCOZ, Dr. Dewi VERNEREY
Nom de la revue : Eur J Cancer.

sample

AbstractBackground: Surgical resection rates remain high in Crohn's disease (CD). Reducing postoperative recurrence...

Posté par : Dr. Dewi VERNEREY, Mr. Antoine FALCOZ
Nom de la revue : Inflamm Bowel Dis.

sample

AbstractPurpose: Cancer patients are at risk of severe COVID-19 infection, and vaccination is recommended....

Posté par : Mr. Antoine FALCOZ
Nom de la revue : Front Immunol

sample

AbstractContext and aims: Eribulin is used in taxane and anthracycline refractory HER2-negative metastatic breast...

Posté par : Mr. Antoine FALCOZ, Dr. Dewi VERNEREY
Nom de la revue : Clin Breast Cancer.

Dernières actualités

Derniers outils

Score de fragilité

Posté par : Dr. Dewi VERNEREY, Mr. Antoine FALCOZ

2015-2024 © Copyright - UMQVC.org

Website by Pearlweb